Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2001
The purpose of this trial is to study the safety and immune response to measles, mumps, and rubella in children who were vaccinated with an investigational measles-mumps-rubella live vaccine made with artificially made human protein.
Epistemonikos ID: 1b002d1352c924e3ceecd27469acee36976d61cf
First added on: Mar 23, 2020